๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to investigate the safety and therapeutic effe...
Status
Unknown
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2016-10
Trial ID
NCT02932826
Treatments Being Tested
To assess the safety and efficacy of CK0802 in treatment of patients with C...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2020-09-29
Trial ID
NCT04468971
The goal of this research study is to determine whether it is safe and prac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-11
Trial ID
NCT03773328
Treatments Being Tested
To assess the safety and tolerability of CK0804 as add-on therapy in partic...
Status
Recruiting
Location
UC Davis Health
Start Date
2022-12-27
Trial ID
NCT05423691
Treatments Being Tested
The goal of this clinical research study is to determine whether it is safe...
Status
Active Not Recruiting
Location
Sarcoma Oncology Research Center, Cancer Center of Southern California
Start Date
2019-05-30
Trial ID
NCT03773393
Treatments Being Tested
RATIONALE: Giving chemotherapy, such as fludarabine and cyclophosphamide, a...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2007-07-23
Trial ID
NCT00602693
The purpose of this study is to determine the efficacy and safety of CK0802...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07576699
RATIONALE: Giving chemotherapy, such as fludarabine and cyclophosphamide, a...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2007-05
Trial ID
NCT00376519
Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-07-30
Trial ID
NCT02423915
This is a unique dose-escalation trial that will titrate doses of umbilical...
Status
Withdrawn
Location
Masonic Cancer Center, University of Minnesota
Start Date
2014-01
Trial ID
NCT01163201